131 related articles for article (PubMed ID: 10443588)
1. Phosducin, beta-arrestin and opioid receptor migration.
Schulz R; Wehmeyer A; Murphy J; Schulz K
Eur J Pharmacol; 1999 Jun; 375(1-3):349-57. PubMed ID: 10443588
[TBL] [Abstract][Full Text] [Related]
2. Effect of phosducin on opioid receptor function.
Schulz R; Wehmeyer A; Schulz K; Murphy J
J Pharmacol Exp Ther; 1999 Apr; 289(1):599-606. PubMed ID: 10087055
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase/mitogen-activated protein kinases block internalization of delta-opioid receptors.
Eisinger DA; Schulz R
J Pharmacol Exp Ther; 2004 May; 309(2):776-85. PubMed ID: 14742744
[TBL] [Abstract][Full Text] [Related]
4. Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3.
Schulz R; Wehmeyer A; Schulz K
J Pharmacol Exp Ther; 2002 Feb; 300(2):376-84. PubMed ID: 11805194
[TBL] [Abstract][Full Text] [Related]
5. Translocation of phosducin in living neuroblastoma x glioma hybrid cells (NG 108-15) monitored by red-shifted green fluorescent protein.
Schulz R; Schulz K; Wehmeyer A; Murphy J
Brain Res; 1998 Apr; 790(1-2):347-56. PubMed ID: 9593987
[TBL] [Abstract][Full Text] [Related]
6. Visualizing preference of G protein-coupled receptor kinase 3 for the process of kappa-opioid receptor sequestration.
Schulz R; Wehmeyer A; Schulz K
Mol Pharmacol; 2002 Jun; 61(6):1444-52. PubMed ID: 12021406
[TBL] [Abstract][Full Text] [Related]
7. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.
Zhang J; Ferguson SS; Barak LS; Bodduluri SR; Laporte SA; Law PY; Caron MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7157-62. PubMed ID: 9618555
[TBL] [Abstract][Full Text] [Related]
8. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
[TBL] [Abstract][Full Text] [Related]
9. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
10. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
11. Morphine-activated opioid receptors elude desensitization by beta-arrestin.
Whistler JL; von Zastrow M
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9914-9. PubMed ID: 9707575
[TBL] [Abstract][Full Text] [Related]
12. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells.
Horner KA; Zadina JE
Brain Res; 2004 Dec; 1028(2):121-32. PubMed ID: 15527737
[TBL] [Abstract][Full Text] [Related]
13. Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin.
Zhang J; Ferguson SS; Law PY; Barak LS; Caron MG
J Recept Signal Transduct Res; 1999; 19(1-4):301-13. PubMed ID: 10071766
[TBL] [Abstract][Full Text] [Related]
14. High-purity selection and maintenance of gene expression in human neuroblastoma cells stably over-expressing GFP fusion protein. Application for opioid receptors desensitization studies.
Aguila B; Roussel M; Jauzac P; Allouche S
Brain Res; 2006 Oct; 1114(1):11-8. PubMed ID: 16938287
[TBL] [Abstract][Full Text] [Related]
15. Phosducin inhibits receptor phosphorylation by the beta-adrenergic receptor kinase in a PKA-regulated manner.
Hekman M; Bauer PH; Söhlemann P; Lohse MJ
FEBS Lett; 1994 Apr; 343(2):120-4. PubMed ID: 8168616
[TBL] [Abstract][Full Text] [Related]
16. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
17. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
Crain SM; Shen KF
Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
[TBL] [Abstract][Full Text] [Related]
18. RGS9-2 is a negative modulator of mu-opioid receptor function.
Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
20. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
